Skip to content

Evaluation of PTB Screening in ANC in Lusaka, Zambia

Pilot Evaluation of Pulmonary Tuberculosis Screening in Antenatal Clinics in Lusaka, Zambia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02053129
Enrollment
5033
Registered
2014-02-03
Start date
2011-11-30
Completion date
2013-12-31
Last updated
2017-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Tuberculosis

Keywords

tuberculosis, HIV, pregnancy

Brief summary

This is a pilot pulmonary TB screening program done in three antenatal care clinics in Lusaka, Zambia to determine the prevalence of culture-confirmed pulmonary tuberculosis and to determine the sensitivity and specificity of symptom-based TB screening.

Detailed description

5000 pregnant women attending antenatal clinics will be evaluated by piloting a TB symptom questionnaire as part of the general health screening done at each visit. Due to the atypical and subclinical presentation of TB in HIV infected patients, culture will be performed on all HIV-infected pregnant women, with or without symptoms, and on all symptomatic HIVnegative women. Referrals for TB treatment in accordance with current national guidelines will be offered.

Interventions

OTHERTB screening Questionnaire

All subjects will be screened with the questionnaire which assesses TB symptoms.

OTHERSputum smear and culture (only in HIV negative women who are symptomatic)

specimens for sputum microscopy and culture collected and processed in accordance with WHO TB Infection Control Guidelines

Sponsors

Centre for Infectious Disease Research in Zambia
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women * 18 years or older * HIV-negative women with any TB symptoms or HIV-infected women regardless of TB symptoms * Attending first ANC visit at one of program clinics

Exclusion criteria

* HIV negative without any TB symptoms

Design outcomes

Primary

MeasureTime frameDescription
number of positive pulmonary tuberculosis (PTB) tests1 day of screening (first antenatal visit)The prevalence of culture confirmed PTB among HIV positive and HIV negative pregnant women will be measured to determine if there is a substantial amount of undiagnosed TB in the HIV positive population accessing antenatal care.

Secondary

MeasureTime frameDescription
Sensitivity and specificity of symptom-based TB screening1 day of screening visitTo determine the sensitivity and specificity of symptom based TB screening (compared to TB culture), enrollees will have TB symptoms assessed by administration of a questionnaire. Culture will then be performed on all HIV infected pregnant women, with or without symptoms, and on all symptomatic HIV negative women.

Countries

Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026